QAT
- Product code
- QAT
- Device name
- Brain Trauma Assessment Test
- Device class
- Class 2
- 21 CFR
- 21 CFR 866.5830
- Medical specialty
- Immunology
- Marketing pathway
- 510(K)
- Flag
- Third-party review eligible
- 510(k) clearances (last 3 years)
- 3
- Summaries archived here
- 3 (direct download)
- 510(k) clearances (all years, FDA)
- 6 (all years; only the last 3 years are listed here)
FDA classification definition
Intended for in vitro diagnostic use as an aid in the evaluation of patients with suspected mild traumatic brain injury (TBI) in conjunction with other clinical information to assist in determining the need for radiologic (e.g., CT, MR) head imaging per current standard of care
510(k) clearances, last 3 years (3)
| Number | Decision date | Applicant | Device name | Summary |
|---|---|---|---|---|
| K240279 | 2024-05-01 | bioMerieux, Inc. | VIDAS TBI (GFAP, UCH-L1) | |
| K234143 | 2024-03-27 | Abbott Point of Care | i-STAT TBI Cartridge with the i-STAT Alinity System | |
| K232669 | 2023-09-29 | Abbott Laboratories | TBI |
Official FDA classification page: QAT
Classification and pathway per current FDA publications. Data from openFDA (CC0).